BiotechTube

Gadoterate (Dotarem/Clariscan) + Gadobutrol (Gadavist/Gadovist, BAY86-4875)

ApprovedCompleted
0 watching 0 views this week🔥 Hot
82
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Magnetic Resonance Imaging

Conditions

Magnetic Resonance Imaging

Trial Timeline

Nov 14, 2018 → May 26, 2020

NCT ID
NCT03602339

About Gadoterate (Dotarem/Clariscan) + Gadobutrol (Gadavist/Gadovist, BAY86-4875)

Gadoterate (Dotarem/Clariscan) + Gadobutrol (Gadavist/Gadovist, BAY86-4875) is a approved stage product being developed by Bayer for Magnetic Resonance Imaging. The current trial status is completed. This product is registered under clinical trial identifier NCT03602339. Target conditions include Magnetic Resonance Imaging.

Hype Score Breakdown

Clinical
30
Activity
20
Company
7
Novelty
10
Community
12

Clinical Trials (1)

NCT IDPhaseStatus
NCT03602339ApprovedCompleted

Competing Products

20 competing products in Magnetic Resonance Imaging

See all competitors
ProductCompanyStageHype Score
HRS-9231 + GadobutrolJiangsu Hengrui MedicinePhase 2
52
D1000078 + D1000082 + D1000083 + D1000085AstraZenecaPhase 1
33
Gadobutrol (Gadavist/Gadovist, BAY86-4875)BayerPre-clinical
20
Gadobutrol (Gadovist, BAY86-4875) + Gadopentetate Dimeglumine (Magnevist, BAY86-4882)BayerPhase 3
74
Gadoquatrane (BAY1747846)BayerPhase 3
74
Gadopentetate dimeglumine (Magnevist, BAY86-4882, SH L 451A) + Gadopentetate dimeglumine (Magnevist, BAY86-4882, SH L 451A)BayerPhase 2
49
GBCAsBayerPre-clinical
20
Gadobutrol (Gadovist, BAY86-4875)BayerPhase 3
74
BAY1747846BayerPhase 1
30
Gadoquatrane (BAY1747846) + Gadobutrol + Gadoterate meglumine + GadoteridolBayerPhase 3
74
Gadobutrol (Gadovist, BAY86-4875)BayerPre-clinical
20
Gadopentetate dimeglumine (Magnevist, BAY86-6661)BayerPhase 3
74
Gadoquatrane (BAY1747846) + Gadobutrol + Gadoterate meglumine + GadoteridolBayerPhase 3
74
Gadobutrol (Gadavist, Gadovist, BAY86-4875)BayerPhase 1
30
Gadobutrol (Gadovist, BAY86-4875)BayerPre-clinical
20
Gadobutrol (Gadavist, BAY86-4875)BayerPhase 1
30
BAY1747846 + Matching placeboBayerPhase 1
30
Gadoquatrane (BAY1747846) 0.03 mmol Gd/kg + Gadoquatrane (BAY1747846) 0.1 mmol Gd/kg + Matching placeboBayerPhase 1
30
Gadobutrol (Gadavist/Gadovist, BAY86-4875)BayerPre-clinical
20
Gadoxetate disodium (Eovist/Primovist, BAY86-4873)BayerPhase 3
74

Other Products from Bayer

TelmisartanApproved
82
Clotrimazole vaginal tablet + FluconazoleApproved
82
Levitra (Vardenafil, BAY38-9456)Approved
82
Avelox (Moxifloxacin, BAY12-8039) + Amoxicillin clavulanic acidApproved
82
Rivaroxaban 20 MG + WarfarinApproved
82